Back to search
Partial Onset Seizures
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Onset Seizures trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Partial Onset Seizures trials you may qualify forThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
The purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
This is a clinical research study for an investigational drug called RAP-219 in patients with Refractory Focal Epilepsy. This study is being conducted to determ…
This is a Phase 2b open-label extension study to evaluate the long-term safety and efficacy of SPN-817.
The purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core st…
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures \[inclu…
A study to determine if BHV- 7000 is safe and tolerable in adults with refractory focal onset epilepsy
Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures
The primary objective of this study is to assess the pharmacokinetics of cenobamate (YKP3089) in pediatric subjects with partial-onset (focal) seizures followin…